What is the main difference between Pancragen and Thymalin?

Pancragen is a Other peptide while Thymalin is a Immune peptide. Pancragen has Low evidence (8 sources) and Thymalin has Moderate evidence (30 sources).

Which has more clinical evidence, Pancragen or Thymalin?

Thymalin has more clinical evidence with 8 human studies compared to 1 for Pancragen. Overall, Thymalin has Moderate evidence strength while Pancragen has Low.

Are Pancragen and Thymalin FDA approved?

Pancragen has Low clinical evidence and is not FDA-approved for general use. Thymalin has moderate clinical evidence from human studies, though its regulatory status varies. Always verify current regulatory status with official sources.

Can Pancragen and Thymalin be combined?

There is no published research on combining Pancragen and Thymalin. The safety and efficacy of any combination is unknown without clinical data.

Other Comparison

Pancragen vs Thymalin

Comparison of Pancragen (Low evidence) and Thymalin (Moderate evidence).

Last updated: February 12, 2026

Pancragen

Low Evidence

View full dossier

Thymalin

Moderate Evidence

View full dossier

Overview

Pancragen and Thymalin are both studied in the peptide research space.

Pancragen: A synthetic tetrapeptide (Lys-Glu-Asp-Trp) developed by Russian scientist Vladimir Khavinson for pancreatic support.

Thymalin: A thymic peptide complex developed in Russia and used clinically in the former Soviet Union for immunomodulation.

Evidence Comparison

Aspect	Pancragen	Thymalin
Evidence Level	Low	Moderate
Human Studies	1	8
Preclinical Studies	6	22
Total Sources	8	30

Key Differences

Aspect	Pancragen	Thymalin
Category	Other	Immune
Evidence Strength	Low	Moderate
Total Sources	8	30
Human Studies	1	8

Summary

Pancragen: Low evidence with 8 total sources (1 human)
Thymalin: Moderate evidence with 30 total sources (8 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

View Full Dossiers

Pancragen Evidence Dossier Thymalin Evidence Dossier

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.